Kawasaki syndrome (mucocutaneous lymph node syndrome);Het syndroom van kawasaki (mucocutaan lymfekliersyndroom)

Tijdschrift voor Geneeskunde

Volumn 57, Issue 3, 2001, Pages 195-201

  Vandekerckhove, K ^a   Van Gysel, D ^a   Bruylants, B ^a  

^a OLV HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 0035254561     PISSN: 0371683X     EISSN: None     Source Type: Journal    
DOI: 10.2143/tvg.57.3.5000959     Document Type: Article

References (39)

1. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children
2. Kawasaki syndrome
3. Kawasaki syndrome
4. Kawasaki syndrome
5. Epidemiology of infant Kawasaki disease with a report of the youngest neonatal case ever reported in Japan
6. Update of the epidemiology of Kawasaki disease in Japan: From the results of the 1993-1994 nationwide survey
7. Kawasaki syndrome: Association with the application of rug shampoo
8. Failure to confirm the presence of a retrovirus in cultured lymphocytes from patients with Kawasaki Syndrome
9. Toxic shock syndrome toxin-1 and V-beta2 expression on T cells in Kawasaki disease
10. Toxic shock syndrome toxin-secreting Staphyloccus aureus in Kawasaki syndrome
11. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease
12. Kawasaki disease - New York
13. Incomplete Kawasaki disease with coronary artery involvement
14. A typical Kawasaki disease: An often missed diagnosis
15. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age
16. Maladie de Kawasaki révélée par une uvéite
17. A study on erythematous change at the site of BCG inoculation
18. Thrombocytopenia: A risk factor for acute myocardial infarction during the acute phase of Kawasaki disease
19. Fate of coronary aneurysms in Kawasaki disease: Serial coronary angiography and long-term follow-up study
20. A new infantile acute febrile mucocutaneous lymph node syndrome prevailing in Japan
21. Two dimensional echocardiography of coronary artery in Kawasaki disease: Detection, changes in acute phase, and follow-up observation of the aneurysm
22. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease
23. Long-term consequences of Kawasaki disease. A 10 to 21-year follow-up study of 594 patients
24. Myocardiol infarction in Kawasaki disease: Clinical analyses in 195 cases
25. Variation in coronary arterial dimension after disappearing aneurysm in Kawasaki disease
26. Vasodilatory response of the coronary arteries after Kawasaki disease: Evaluation by intracoronary injection of isosorbide dinitrate
27. Mucocutaneous lymph node syndrome: Delayed aortic and mitral insufficiency secondary to active valvulitis
28. Kawasaki disease: Cardiac problems and management
29. Severe mitral regurgitation due to coronary arteritis of mucocutaneous lymph node syndrome
30. Evaluation method for the degree of seriousness in Kawasaki disease
31. Kawasaki disease: More patients are being diagnosed who do not meet American Heart Association criteria
32. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome
33. Management of Kawasaki syndrome: A consensus statement prepared by North American participants of the Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988
34. The treatment of Kawasaki syndrome with intravenous gammaglobulin
35. IVGG therapy in Kawasaki disease: Mechanism(s) of action
36. Gamma globulin re-treatment in Kawasaki disease
37. Intravenous gamma globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group
38. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound